Stockscreener 앱 받기
28.07
4.46%
-1.31
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers Health Inc (HIMS) Stock Down 4.5% -- Now Undervalued? GF Score: 75/100 - GuruFocus
ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRP - GlobeNewswire Inc.
HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
What Does Hims & Hers Health (HIMS) Expansion Into The UK And Australia Mean? - Yahoo Finance
Hims & Hers Health (HIMS) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline - PR Newswire
How Is Hims & Hers Health, Inc. (NYSE:HIMS) Reshaping Its Business? - Kalkine Media
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - The Killeen Daily Herald
Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc - The National Law Review
Hims & Hers Health rises as HHS moves ahead with plan for compounding peptides - Seeking Alpha
US FDA takes step to change peptide compounding policy - Reuters
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Our Commitment to Independent, Clinician-Led Care - Hims & Hers Newsroom
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP AnnouncesHIMS - GlobeNewswire Inc.
Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action - GlobeNewswire Inc.
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNovember 2, 2026 Deadline - PR Newswire
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights - Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Hims & Hers Expands Australian Women's Health Platform With Hers - Zacks Investment Research
Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - PR Newswire
Innovating for Her - Hims & Hers Newsroom
HIMS DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
PZZA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Papa John’s International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionPZZA - GlobeNewswire Inc.
Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - GlobeNewswire Inc.
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Hims & Hers Health: The Bullish Case Is Hard To Forecast, But It Is Asymmetrical - Seeking Alpha
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, - GlobeNewswire
Should You Trim Or Add To Your Hims & Hers Position Now? - Trefis
Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investo - The National Law Review
Hims & Hers Launches Hers Women’s-Health Platform in Australia - www.tokenpost.com
Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026 - HIMS investor relations
Hims & Hers (HIMS) Launches Hers Brand in Australia, Expanding W - GuruFocus
Hers Launches in Australia - Hims & Hers Newsroom
Hers Launches in Australia, Built to Care for the Whole Woman - Business Wire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
Hims & Hers Health, Inc. (HIMS) Stock Forecasts - Yahoo Finance
Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud - GlobeNewswire
Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply LowerHBSS - GlobeNewswire Inc.
Hims & Hers Health climbs 10% amid recent volatile trading (HIMS:NYSE) - Seeking Alpha
Hims & Hers Health Jumps 7.3% Amid Sector-Wide Rally - AlphaStreet
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - WBOC TV
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today - Yahoo Finance
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now - The Globe and Mail
Hims & Hers Health Shares Slide as Investors Weigh Accounting Leadership Change and Ongoing Margin Questions - Quiver Quantitative
0.29%
2.79%
자본화:
|
볼륨(24시간):